vimarsana.com
Home
Live Updates
Swedish Orphan Biovitrum : 22 March – Phase 3 study r
Swedish Orphan Biovitrum : 22 March – Phase 3 study r
Swedish Orphan Biovitrum : 22 March – Phase 3 study results SEL-212
Both Phase 3 Studies and both tested doses met primary efficacy endpoints, achieving a statistically significant response rate with SEL-212 versus placebo
... | March 27, 2023
Related Keywords
,
Both Phase ,
Global Studies ,
Rheumatology Common Toxicity Criteria ,
Swedish Orphan Biovitrum Ab Publ Stock Exchange ,
News ,
Information ,
Press Release ,
Moth ,
Hase ,
Studies ,
End ,
Tested ,
Doses ,
Pet ,
Primary ,
Efficacy ,
Chieving ,
Statistically ,
Significant ,
Response ,
Gate ,
Ith ,
Ersus Sobi Se0000872095 ,